APP receives FDA marketing approval for Metoprolol Tartrate Injection APP Pharmaceuticals.

Regarding to IMS Health, product sales of this product in the usa for 2009 were approximately $13 million. ‘Cardiovascular disease is a leading cause of death in the United States and APP’s acceptance of Metoprolol Tartrate Injection, USP, provides an affordable, generic treatment for millions of individuals who suffer a heart attack or acute myocardial infarction each year,’ said John Ducker, Chief and President Executive Officer of APP Pharmaceuticals. ‘Additionally, this approval further expands APP’s growing Important Care products.’ APP’s Metoprolol Tartrate Injection, USP is AP-rated, preservative-free and bar-coded, and is usually packaged in single dose 5 mg/5 mL vials. The Centers for Disease Control and Prevention has specified vaccination as the most powerful public health device to control influenza.Servan-Schreiber were able to extend his existence for 19 years, living as he do with an inoperable brain tumor. He describes several approaches to managing cancer as a chronic condition in his publication, approaches which include enhancing the disease fighting capability, ingesting spices and foods known to fight cancer, reducing inflammation and becoming well balanced in body, mind and spirit. In the reserve Radical Remission, Dr. Kelly Turner, PhD, describes her quest to discover just what allowed people, some with advanced cancers seriously, to achieve a complete remission.